Vulvovaginalna kandidoza Karelović, Deni; Karelović, Lukrecija; Zekan, Joško
Medicus (Zagreb, Croatia : 1992),
01/2012, Letnik:
21, Številka:
1_UGI
Journal Article
Recenzirano
Odprti dostop
Vulvovaginalna je mikoza, nakon bakterijske, najčešća vaginalna infekcija. Česta je bolest mladih žena i nalazi se u 15-30% simptomatskih žena koje posjećuju liječnika. Prevalencija u općoj ...populaciji iznosi 5-15%. Najčešći uzročnik je Candida albicans i odgovorna je za 80-92% epizoda vulvovaginalne mikoze. Vulvovaginalna kandidoza nije spolno prenosiva bolest. Candida spp. čini dio fiziološke flore rodnice u 20-50% zdravih asimptomatskih žena. Glavni simptom je svrbež, s malo vaginalnog sekreta ili bez njega koji je tipično bijel, grudast i sirast. Mogu biti prisutni i bolnost, nadražaj, pečenje, disurija i dispareunija. Dijagnoza se postavlja nalazom gljive na mokrom preparatu iscjetka s dodatkom 10%-tnog kalijeva hidroksida. Mikroskopija je lažno negativna u 50% bolesnica s potvrđenom vulvovaginalnom kandidozom. Potrebno je napraviti kulturu bolesnicama s karakterističnim simptomima i negativnom mikroskopijom. Asimptomatska kolonizacija nije indikacija za liječenje. Vrsta i trajanje liječenja simptomatske bolesti određuju se temeljem osnovne podjele na nekomplicirani i komplicirani oblik bolesti. Nekomplicirani se oblik podjednako uspješno liječi lokalnim i sistemskim lijekovima. Optimalno je liječenje jednokratna primjena oralnog flukonazola (Zenafluk®, PLIVA) u dozi od 150 mg. Komplicirane infekcije liječe se dulje.
U ginekološkim ordinacijama primarne zdravstvene zaštite u Hrvatskoj, u razdoblju od 01.06.2006. do 31.07.2006. godine ispitano je 246 epizoda nekomplicirane vulvovaginalne kandidoze (VVK) u ...bolesnica dobi od 18 do 45 godina u kojih su simptomi trajali do dva tjedna prije početka liječenja. Pojavi VVK u 83 bolesnice prethodilo je uzimanje antibiotika, mjesečnica ili primjena oralnih kontraceptiva. Ostale bolesnice nisu imale predisponirajuće čimbenike. Seksualni partneri nisu imali balanitis. Bolesnice su liječene prema listi randomizacije klotrimazolom vaginalno – 1×0,2 g kroz 3 dana, odnosno flukonazolom peroralno – 1×150 mg jednokratno. Randomizacijom su određene bolesnice čiji su seksualni partneri primali peroralno flukonazol 1×150 mg jednokratno.
Klinička djelotvornost antimikrobnog liječenja nekomplicirane VVK i učestalost pojave ponovnih epizoda VVK nisu se značajno razlikovale s obzirom na vrstu provedenog liječenja i istovremeno liječenje ili neliječenje partnera.
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- V posledních dvaceti letech došlo ...k nárůstu počtu invazivních mykotických infekcí, které navzdory pokrokům v diagnostice a léčbě zůstávají signifikantní příčinou mortality u pacientů se závažnými onemocněními.- A increase in the frequency of systemic fungal infection was observed in the last twenty years. These still remain a significant cause of mortality in patients with serious diseases despite improvements in diagnostic tools and treatment.- Iva Kocmanová- Literatura- All metadata published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- Literatura- All metadata published ...by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- Background: The information on the ...prevalence of vulvovaginal candidiasis does not always reflect real situation regarding this disease, since the frequency of patients’ self- treatment remains high, as evidenced by the results of the studies based on anonymous surveys. The prevalence of this disease is growing steadily both in Uzbekistan and elsewhere in the world. Accumulated problems have provided grounds to conduct the research on the prevalence of Candida vulvovaginitis in the juvenile age population of Tashkent city. Method: The study included examining of 2107 adolescent aged girls of high schools, lyceums and colleges of Tashkent city. Results: Thus, in the studied region the prevalence of Candida vulvovaginitis in adolescent population is high, which in turn requires to take steps to further improve treatment and prevention.- Uktam Ziyadullaev- Literatura- All metadata published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- BACKGROUND: Human immunodeficiency ...virus (HIV) continues to be a serious health issue and one of the world most devastating epidemics. An estimated 1.5 million people died from AIDS-related illnesses in 2013, and an estimated 37 million people with AIDS have died worldwide since the epidemic has begun. HIV infection is known for its oral manifestations which causes discomfort and pain for infected individuals. The objective of this study was to document oral conditions of HIV positive patients and the pattern and frequency of oral and dental lesions. METHODS: All patients with confirmed HIV infection who were treated at the Department of Dentistry, University Hospital in Hradec Králové, were examined. RESULTS: During the study period, 29 HIV positive patients were examined and treated--19 men, 10 women, with mean age of 32.9 years (range 22-58 years). 72.41% patients received ART. In total, all patients underwent 186 visits. The most frequent treatments were associated with teeth and periodontal lesions (71.80%), oral mucosal lesions were diagnosed and treated only in 3.96% cases. CONCLUSION: Since the introduction of ART, the frequency of oral mucosal lesions is minimal in patients with HIV infection.- M. Šembera, V. Radochová, R. Slezák- All metadata published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- Článek se zabývá klinickým obrazem ...a lerapii nejčastějších mykóz kůže a sliznic, které postihují osoby ve vyšším věku. Tinea nohou probíhá často nepoznána. Naproti tomu onychomykózu je nutno odlišit od nemykotických onychopatií. Snížená imunita ve vyšším věku a polymorbidita predisponují ke vzniku slizničních a kožnich kandidóz.- The article describes the clinical picture and therapy of the most important skin and mucosal mycoses in the senior population. A tinea of the soles is often neglected. On the other hand, onychomycosis must be distinguished from non-mycotic onychopathias. Impaired imunity in advanced age as well as polymorbidity predisposes to mucosal and skin candidoses.- Magdalena Skořepová- Lit. 11- All metadata published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- Invazívne mykotické infekcie ...predstavujú závažnú infekčnú komplikáciu imunokompromitovaných pacientov. V porovnaní s bakteriálnymi infekciami je ich výskyt menej častý, na druhú stranu mortalita s nimi spojená je výrazne vyššia než je tomu u infekcií bakteriálnych. Posledné dve desaťročia priniesli významné zmeny v epidemiológii invazívnych mykóz a behom posledných niekoľkých rokov došlo k značným pokrokom v diagnostike a liečbe.- Invasive fungal infections are serious life-threatening complication in immunocompromised patients. They are rare in comparison with bacterial infection but attributable mortality is higher. Last two decades brought significant changes in epidemiology of invasive fungal diseases and the last few years brought much progress in diagnostics and treatment.- Martina Tošková, Jana Winterová, Iva Kocmanová, Zdeněk Ráčil- Literatura- All metadata published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- V průběhu posledních let dochází k ...nárůstu počtu imunosuprimovaných nemocných a tím i k vzestupu invazivních mykotických onemocnění. Terapie hlubokých mykóz je mnohdy obtížná, mortalita a morbidita těchto infekčních komplikací jsou vysoké. Stále lepší dostupnost nových antimykotik rozšiřuje naše léčebné možnosti a zlepšuje výsledky terapie těchto invazivních mykotických infekcí. Předkládaná práce podává informace o využití jednotlivých antimykotik v léčbě invazivních mykóz, shrnuje léčbu invazivní aspergilózy (IA), invazivní kandidózy (IC) a empirickou antimykotickou terapii. Doporučení vychází ze závěrů prezentovaných Europen Conference on Infection in Leukemia (ECIL).- The frequency of invasive fungal infections has significantly increased with the rise in at-risk populations of patients in the last years. Management of deep fungal infection is difficult and the morbidity and mortality of these infections are very high. New antifungal agents provide the managment options and improve therapeutic outcomes of these infections. This article informs about the role of available antifungal agents in the management of invasive fungal infections and reviews empirical antifungal treatmnet and the treatment of invasive aspergillus and candida infections. Recommendations presented below are based on the resume of the Europen Conference on Infection in Leukemia (ECIL).- Jana Diatková, Martina Tošková, Iva Kocmanová, Jiří Mayer, Zdeněk Ráčil- Literatura- All metadata published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
Provider: Czech digital library/Česká digitální knihovna - Institution: National Medical Library/Národní lékařská knihovna - Data provided by Europeana Collections- D. Makalová- All metadata ...published by Europeana are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, Europeana requests that you actively acknowledge and give attribution to all metadata sources including Europeana
